TScan Therapeutics(TCRX) - 2024 Q3 - Quarterly Report
TScan Therapeutics(TCRX)2024-11-12 12:30UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 or | --- | --- | --- | --- | --- | --- | |----------------------------------------------------------------------------|--------------------------------------------------------------------------------------|------------------------------------------------------------------------- ...